230 related articles for article (PubMed ID: 35763053)
1. Preoperative prediction of pelvic lymph nodes metastasis in prostate cancer using an ADC-based radiomics model: comparison with clinical nomograms and PI-RADS assessment.
Liu X; Wang X; Zhang Y; Sun Z; Zhang X; Wang X
Abdom Radiol (NY); 2022 Sep; 47(9):3327-3337. PubMed ID: 35763053
[TBL] [Abstract][Full Text] [Related]
2. Histological comparison between predictive value of preoperative 3-T multiparametric MRI and
Franklin A; Yaxley WJ; Raveenthiran S; Coughlin G; Gianduzzo T; Kua B; McEwan L; Wong D; Delahunt B; Egevad L; Samaratunga H; Brown N; Parkinson R; Roberts MJ; Yaxley JW
BJU Int; 2021 Jan; 127(1):71-79. PubMed ID: 32524748
[TBL] [Abstract][Full Text] [Related]
3. Radiomics Models Based on Apparent Diffusion Coefficient Maps for the Prediction of High-Grade Prostate Cancer at Radical Prostatectomy: Comparison With Preoperative Biopsy.
Han C; Ma S; Liu X; Liu Y; Li C; Zhang Y; Zhang X; Wang X
J Magn Reson Imaging; 2021 Dec; 54(6):1892-1901. PubMed ID: 33682286
[TBL] [Abstract][Full Text] [Related]
4. Utility of diffusion weighted imaging-based radiomics nomogram to predict pelvic lymph nodes metastasis in prostate cancer.
Liu X; Tian J; Wu J; Zhang Y; Wang X; Zhang X; Wang X
BMC Med Imaging; 2022 Nov; 22(1):190. PubMed ID: 36333664
[TBL] [Abstract][Full Text] [Related]
5. Development and External Validation of a Novel Nomogram to Predict the Probability of Pelvic Lymph-node Metastases in Prostate Cancer Patients Using Magnetic Resonance Imaging and Molecular Imaging with Prostate-specific Membrane Antigen Positron Emission Tomography.
Vis AN; Meijer D; Roberts MJ; Siriwardana AR; Morton A; Yaxley JW; Samaratunga H; Emmett L; van de Ven PM; Heymans MW; Nieuwenhuijzen JA; van der Poel HG; Donswijk ML; Boellaard TN; Schoots IG; Stricker P; Haynes AM; Oprea-Lager DE; Coughlin GD; van Leeuwen PJ
Eur Urol Oncol; 2023 Dec; 6(6):553-563. PubMed ID: 37045707
[TBL] [Abstract][Full Text] [Related]
6. Identification of the Optimal Candidates for Nodal Staging with Extended Pelvic Lymph Node Dissection Among Prostate Cancer Patients Who Underwent Preoperative Prostate-specific Membrane Antigen Positron Emission Tomography. External Validation of the Memorial Sloan Kettering Cancer Center and Briganti Nomograms and Development of a Novel Tool.
Gandaglia G; Barletta F; Robesti D; Scuderi S; Rajwa P; Gomez Rivas J; Ibanez L; Soeterik TFW; Bianchi L; Afferi L; Kesch C; Darr C; Guo H; Zhuang J; Zattoni F; Fendler W; Marra G; Stabile A; Amparore D; Huebner NA; Giesen A; Joniau S; Schiavina R; Brunocilla E; Mattei A; Dal Moro F; Sierra JM; Porpiglia F; Picchio M; van den Bergh R; Shariat SF; Montorsi F; Briganti A
Eur Urol Oncol; 2023 Dec; 6(6):543-552. PubMed ID: 37270378
[TBL] [Abstract][Full Text] [Related]
7. Prediction of pelvic lymph node metastasis in prostate cancer using radiomics based on T
Liu X; Zhang Y; Sun Z; Wang X; Zhang X; Wang X
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Aug; 47(8):1025-1036. PubMed ID: 36097770
[TBL] [Abstract][Full Text] [Related]
8. Integration of clinicopathologic identification and deep transferrable image feature representation improves predictions of lymph node metastasis in prostate cancer.
Hou Y; Bao J; Song Y; Bao ML; Jiang KW; Zhang J; Yang G; Hu CH; Shi HB; Wang XM; Zhang YD
EBioMedicine; 2021 Jun; 68():103395. PubMed ID: 34049247
[TBL] [Abstract][Full Text] [Related]
9. Preoperative PI-RADS Version 2 scores helps improve accuracy of clinical nomograms for predicting pelvic lymph node metastasis at radical prostatectomy.
Huang C; Song G; Wang H; Lin Z; Wang H; Ji G; Zhang S; Guo Y; Li J; Bao Z; Hong P; Du Y; Li P; He Q; He S; Gong Y; Wang X; Zhou L
Prostate Cancer Prostatic Dis; 2020 Mar; 23(1):116-126. PubMed ID: 31383954
[TBL] [Abstract][Full Text] [Related]
10. Indications for and complications of pelvic lymph node dissection in prostate cancer: accuracy of available nomograms for the prediction of lymph node invasion.
Oderda M; Diamand R; Albisinni S; Calleris G; Carbone A; Falcone M; Fiard G; Gandaglia G; Marquis A; Marra G; Parola C; Pastore A; Peltier A; Ploussard G; Roumeguère T; Sanchez-Salas R; Simone G; Smelzo S; Witt JH; Gontero P
BJU Int; 2021 Mar; 127(3):318-325. PubMed ID: 32869940
[TBL] [Abstract][Full Text] [Related]
11. External Validation and Addition of Prostate-specific Membrane Antigen Positron Emission Tomography to the Most Frequently Used Nomograms for the Prediction of Pelvic Lymph-node Metastases: an International Multicenter Study.
Meijer D; van Leeuwen PJ; Roberts MJ; Siriwardana AR; Morton A; Yaxley JW; Samaratunga H; Emmett L; van de Ven PM; van der Poel HG; Donswijk ML; Boellaard TN; Schoots IG; Oprea-Lager DE; Coughlin GD; Vis AN
Eur Urol; 2021 Aug; 80(2):234-242. PubMed ID: 34024652
[TBL] [Abstract][Full Text] [Related]
12. External validation of the Memorial Sloan Kettering Cancer Centre and Briganti nomograms for the prediction of lymph node involvement of prostate cancer using clinical stage assessed by magnetic resonance imaging.
Soeterik TFW; Hueting TA; Israel B; van Melick HHE; Dijksman LM; Stomps S; Biesma DH; Koffijberg H; Sedelaar M; Witjes JA; van Basten JA
BJU Int; 2021 Aug; 128(2):236-243. PubMed ID: 33630398
[TBL] [Abstract][Full Text] [Related]
13. Multiparametric MRI-based radiomics model to predict pelvic lymph node invasion for patients with prostate cancer.
Zheng H; Miao Q; Liu Y; Mirak SA; Hosseiny M; Scalzo F; Raman SS; Sung K
Eur Radiol; 2022 Aug; 32(8):5688-5699. PubMed ID: 35238971
[TBL] [Abstract][Full Text] [Related]
14. A Novel Nomogram to Identify Candidates for Extended Pelvic Lymph Node Dissection Among Patients with Clinically Localized Prostate Cancer Diagnosed with Magnetic Resonance Imaging-targeted and Systematic Biopsies.
Gandaglia G; Ploussard G; Valerio M; Mattei A; Fiori C; Fossati N; Stabile A; Beauval JB; Malavaud B; Roumiguié M; Robesti D; Dell'Oglio P; Moschini M; Zamboni S; Rakauskas A; De Cobelli F; Porpiglia F; Montorsi F; Briganti A
Eur Urol; 2019 Mar; 75(3):506-514. PubMed ID: 30342844
[TBL] [Abstract][Full Text] [Related]
15. External Validation of the 2019 Briganti Nomogram for the Identification of Prostate Cancer Patients Who Should Be Considered for an Extended Pelvic Lymph Node Dissection.
Gandaglia G; Martini A; Ploussard G; Fossati N; Stabile A; De Visschere P; Borgmann H; Heidegger I; Steinkohl F; Kretschmer A; Marra G; Mathieu R; Surcel C; Tilki D; Tsaur I; Valerio M; Van den Bergh R; Ost P; Gontero P; Montorsi F; Briganti A;
Eur Urol; 2020 Aug; 78(2):138-142. PubMed ID: 32268944
[TBL] [Abstract][Full Text] [Related]
16. Development and Internal Validation of a Novel Model to Identify the Candidates for Extended Pelvic Lymph Node Dissection in Prostate Cancer.
Gandaglia G; Fossati N; Zaffuto E; Bandini M; Dell'Oglio P; Bravi CA; Fallara G; Pellegrino F; Nocera L; Karakiewicz PI; Tian Z; Freschi M; Montironi R; Montorsi F; Briganti A
Eur Urol; 2017 Oct; 72(4):632-640. PubMed ID: 28412062
[TBL] [Abstract][Full Text] [Related]
17. First North American validation and head-to-head comparison of four preoperative nomograms for prediction of lymph node invasion before radical prostatectomy.
Bandini M; Marchioni M; Pompe RS; Tian Z; Gandaglia G; Fossati N; Abdollah F; Graefen M; Montorsi F; Saad F; Shariat SF; Briganti A; Karakiewicz PI
BJU Int; 2018 Apr; 121(4):592-599. PubMed ID: 29124911
[TBL] [Abstract][Full Text] [Related]
18. PI-RADS version 2: Preoperative role in the detection of normal-sized pelvic lymph node metastasis in prostate cancer.
Park SY; Shin SJ; Jung DC; Cho NH; Choi YD; Rha KH; Hong SJ; Oh YT
Eur J Radiol; 2017 Jun; 91():22-28. PubMed ID: 28629566
[TBL] [Abstract][Full Text] [Related]
19. Predictive Value of Cribriform and Intraductal Carcinoma for the Nomogram-based Selection of Prostate Cancer Patients for Pelvic Lymph Node Dissection.
de Barros HA; Remmers S; Luiting HB; van Leenders GJLH; Roobol MJ; Bekers EM; Amin A; Haynes AM; Delprado W; Stricker PD; van der Poel HG; van der Kwast TH; van Leeuwen PJ
Urology; 2022 Oct; 168():156-164. PubMed ID: 35803346
[TBL] [Abstract][Full Text] [Related]
20. Feasibility of an ADC-based radiomics model for predicting pelvic lymph node metastases in patients with stage IB-IIA cervical squamous cell carcinoma.
Yu YY; Zhang R; Dong RT; Hu QY; Yu T; Liu F; Luo YH; Dong Y
Br J Radiol; 2019 May; 92(1097):20180986. PubMed ID: 30888846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
